News Focus
News Focus
Replies to #67609 on Biotech Values
icon url

DewDiligence

10/22/08 12:52 AM

#67614 RE: tinkershaw #67609

ELN/BIIB – Forbes needs a better calculator:

http://www.forbes.com/2008/10/21/biogen-idec-biotech-markets-equity-cx_lal_1021markets24.html

>>
As of the end of September, more than 35,500 patients were on Tysabri, the mulitple sclerosis drug in question, down from 31,800 at the end of the second quarter.

<<

:- )